Articles with public access mandates - Erin D MilliganLearn more
Not available anywhere: 1
Preclinical chorioamnionitis dysregulates CXCL1/CXCR2 signaling throughout the placental-fetal-brain axis
TR Yellowhair, S Noor, JR Maxwell, CV Anstine, AY Oppong, S Robinson, ...
Experimental neurology 301, 110-119, 2018
Mandates: US National Institutes of Health, American Heart Association
Available somewhere: 42
Pathological and protective roles of glia in chronic pain
ED Milligan, LR Watkins
Nature reviews neuroscience 10 (1), 23-36, 2009
Mandates: US National Institutes of Health
Glia in pathological pain: a role for fractalkine
ED Milligan, EM Sloane, LR Watkins
Journal of neuroimmunology 198 (1-2), 113-120, 2008
Mandates: US National Institutes of Health
Cytokines in pain: harnessing endogenous anti-inflammatory signaling for improved pain management
AG Vanderwall, ED Milligan
Frontiers in immunology 10, 3009, 2019
Mandates: US National Institutes of Health
Chemokine action in the nervous system
RJ Miller, W Rostene, E Apartis, G Banisadr, K Biber, ED Milligan, ...
Journal of Neuroscience 28 (46), 11792-11795, 2008
Mandates: US National Institutes of Health
Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain
LC Loram, JA Harrison, EM Sloane, MR Hutchinson, P Sholar, FR Taylor, ...
Journal of Neuroscience 29 (44), 14015-14025, 2009
Mandates: US National Institutes of Health
Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with …
E Sloane, A Ledeboer, W Seibert, B Coats, M Van Strien, SF Maier, ...
Brain, behavior, and immunity 23 (1), 92-100, 2009
Mandates: US National Institutes of Health
Mesoporous silica-supported lipid bilayers (protocells) for DNA cargo delivery to the spinal cord
EC Dengler, J Liu, A Kerwin, S Torres, CM Olcott, BN Bowman, L Armijo, ...
Journal of Controlled Release 168 (2), 209-224, 2013
Mandates: US National Institutes of Health
Release of plasmid DNA-encoding IL-10 from PLGA microparticles facilitates long-term reversal of neuropathic pain following a single intrathecal administration
RG Soderquist, EM Sloane, LC Loram, JA Harrison, EC Dengler, ...
Pharmaceutical research 27, 841-854, 2010
Mandates: US National Institutes of Health
Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels
JL Wilkerson, KR Gentry, EC Dengler, JA Wallace, AA Kerwin, LM Armijo, ...
PAIN® 153 (5), 1091-1106, 2012
Mandates: US National Institutes of Health
Spinal interleukin-10 therapy to treat peripheral neuropathic pain
ED Milligan, KR Penzkover, RG Soderquist, MJ Mahoney
Neuromodulation: Technology at the Neural Interface 15 (6), 520-526, 2012
Mandates: US National Institutes of Health
Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti‐inflammatory cytokine responses in neuropathic rats exhibiting …
JL Wilkerson, KR Gentry, EC Dengler, JA Wallace, AA Kerwin, MN Kuhn, ...
Brain and behavior 2 (2), 155-177, 2012
Mandates: US National Institutes of Health
PEGylation of brain‐derived neurotrophic factor for preserved biological activity and enhanced spinal cord distribution
RG Soderquist, ED Milligan, EM Sloane, JA Harrison, KK Douvas, ...
Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2009
Mandates: US National Institutes of Health
Improvement of spinal non-viral IL-10gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain
EC Dengler, LA Alberti, BN Bowman, AA Kerwin, JL Wilkerson, ...
Journal of neuroinflammation 11, 1-21, 2014
Mandates: US National Institutes of Health
Aging exacerbates neuroinflammatory outcomes induced by acute ozone exposure
CR Tyler, S Noor, TL Young, V Rivero, B Sanchez, S Lucas, KK Caldwell, ...
Toxicological Sciences 163 (1), 123-139, 2018
Mandates: US Department of Energy, US National Institutes of Health
Effects of spinal non-viral interleukin-10 gene therapy formulated with d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein …
AG Vanderwall, S Noor, MS Sun, JE Sanchez, XO Yang, LL Jantzie, ...
Brain, behavior, and immunity 69, 91-112, 2018
Mandates: US National Institutes of Health
Long-term control of neuropathic pain in a non-viral gene therapy paradigm
EM Sloane, RG Soderquist, SF Maier, MJ Mahoney, LR Watkins, ...
Gene therapy 16 (4), 470-475, 2009
Mandates: US National Institutes of Health
Lifelong impacts of moderate prenatal alcohol exposure on neuroimmune function
S Noor, ED Milligan
Frontiers in immunology 9, 1107, 2018
Mandates: US National Institutes of Health
Prenatal alcohol exposure potentiates chronic neuropathic pain, spinal glial and immune cell activation and alters sciatic nerve and DRG cytokine levels
S Noor, JJ Sanchez, AG Vanderwall, MS Sun, JR Maxwell, S Davies, ...
Brain, behavior, and immunity 61, 80-95, 2017
Mandates: US National Institutes of Health
Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain
E Sloane, S Langer, B Jekich, J Mahoney, T Hughes, M Frank, W Seibert, ...
Gene therapy 16 (10), 1210-1222, 2009
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program